Be a Smart Investor
Monday, January 29, 2018
Big pharma paying top dollar for biotech assets: Pro
"At some point this has to end," John Rountree, partner at Novasecta Limited, says of consolidation in the pharmaceuticals sector.
from Mergers and Acquisitions http://ift.tt/2El3abl
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment